Bio-Techne Corporation (NASDAQ:TECH) Q2 2026 earnings call transcript

Bio-Techne Corporation (NASDAQ:TECH) Q2 2026 Earnings Call Transcript February 4, 2026 Bio-Techne Corporation beats earnings ...

Avobis Bio Announces Expanded Primary Analysis Results from the Randomized Multicenter STOMP2 Clinical Trial to be Presented at European Crohn's and Colitis O…

Avobis Bio LLC, a clinical stage company developing implantable cell therapies, announced that expanded primary analysis ...
Le Lézard

NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences

NewcelX Ltd. ("NewcelX" or the "Company"), a clinical-stage cell therapy company advancing transformative treatments for ...
Nature

Reporting standards and availability of data, materials, code and protocols

An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...